"Herpes Zoster Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An attenuated vaccine used to prevent and/or treat HERPES ZOSTER, a disease caused by HUMAN HERPESVIRUS 3.
Descriptor ID |
D053061
|
MeSH Number(s) |
D20.215.894.899.290.130.400
|
Concept/Terms |
Herpes Zoster Vaccine- Herpes Zoster Vaccine
- Vaccine, Herpes Zoster
- Zoster Vaccine
- Vaccine, Zoster
- Shingles Vaccine
- Vaccine, Shingles
|
Below are MeSH descriptors whose meaning is more general than "Herpes Zoster Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Herpes Zoster Vaccine".
This graph shows the total number of publications written about "Herpes Zoster Vaccine" by people in this website by year, and whether "Herpes Zoster Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2017 | 11 | 1 | 12 |
2018 | 16 | 1 | 17 |
2019 | 8 | 2 | 10 |
2021 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Herpes Zoster Vaccine" by people in Profiles.
-
Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults. J Eur Acad Dermatol Venereol. 2021 Dec; 35(12):e846-e847.
-
Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series. J Eur Acad Dermatol Venereol. 2021 Dec; 35(12):e845-e846.
-
Herpes Zoster following SARS-CoV-2 vaccination - a series of four cases. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e750-e752.
-
A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster. Int J Rheum Dis. 2021 Aug; 24(8):979-983.
-
Healthcare workers' perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2021 07 20; 7:CD013706.
-
Safety of live attenuated herpes zoster vaccine in Australian adults 70-79 years of age: an observational study using active surveillance. BMJ Open. 2021 03 25; 11(3):e043880.
-
Vaccines for older adults. BMJ. 2021 02 22; 372:n188.
-
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines. Blood. 2021 01 14; 137(2):185-189.
-
Why vaccines matter. Drug Ther Bull. 2021 Feb; 59(2):18.
-
Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial. Ann Rheum Dis. 2019 12; 78(12):1663-1668.